載入...
New perspectives for targeting RAF kinase in human cancer
The discovery that a subset of human tumours is dependent on mutationally deregulated BRAF kinase intensified the development of RAF inhibitors to be used as potential therapeutics. The US Food and Drug Administration (FDA)-approved second-generation RAF inhibitors vemurafenib and dabrafenib have el...
Na minha lista:
| 發表在: | Nat Rev Cancer |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000833/ https://ncbi.nlm.nih.gov/pubmed/28984291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc.2017.79 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|